Explore

Trendline Trendline
Secretome Therapeutics to Participate in Summer 2026 Investor Conferences

Secretome Therapeutics to Participate in Summer 2026 Investor Conferences

Secretome Therapeutics to Participate in Summer 2026 Investor Conferences
Trendline Trendline
Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development

Enveric Biosciences Reports First Quarter 2026 Financial Results and Advances Drug Development
Trendline Trendline
Marker Therapeutics Reports Improved Financials Amidst Ongoing Clinical Developments

Marker Therapeutics Reports Improved Financials Amidst Ongoing Clinical Developments

Marker Therapeutics Reports Improved Financials Amidst Ongoing Clinical Developments
Trendline Trendline
Gossamer Bio Reports Q1 2026 Financial Results and Advances Seralutinib Development

Gossamer Bio Reports Q1 2026 Financial Results and Advances Seralutinib Development

Gossamer Bio Reports Q1 2026 Financial Results and Advances Seralutinib Development
Trendline Trendline
Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth

Sensei Biotherapeutics Advances Cancer Treatment with PIKTOR Amid Financial Growth
Trendline Trendline
Marker Therapeutics Reports Q1 2026 Financial Results with Reduced Losses

Marker Therapeutics Reports Q1 2026 Financial Results with Reduced Losses

Marker Therapeutics Reports Q1 2026 Financial Results with Reduced Losses
Trendline Trendline
Resideo Technologies to Engage in Key Investor Conferences, Highlighting Strategic Market Position

Resideo Technologies to Engage in Key Investor Conferences, Highlighting Strategic Market Position

Resideo Technologies to Engage in Key Investor Conferences, Highlighting Strategic Market Position
Trendline Trendline
Legend Biotech Reports Strong Q1 2026 Growth Driven by CARVYKTI Expansion

Legend Biotech Reports Strong Q1 2026 Growth Driven by CARVYKTI Expansion

Legend Biotech Reports Strong Q1 2026 Growth Driven by CARVYKTI Expansion
Trendline Trendline
Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials

Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials

Inhibrx Biosciences Reports Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements

NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements

NanoViricides Reports $1.99M Net Loss in Q3 FY2026 Amid Clinical Advancements
Trendline Trendline
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase

Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase

Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase
Trendline Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements